Phibro Animal Health Corporation

Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets animal health products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics for treating infestations of parasitic intestinal worms; anti-bloat treatment products used in cattle to control bloat in animals grazing on legume, or wheat-pasture; and medicated feed additives and other related products. The company’s animal health products also comprise nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily in the poultry and swine industries. In addition, it manufactures and markets approximately formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds.

Company Growth (employees)
Teaneck, US
Size (employees)
1,300 (est)
Phibro Animal Health Corporation was founded in 2003 and is headquartered in Teaneck, US

Phibro Animal Health Corporation Office Locations

Phibro Animal Health Corporation has an office in Teaneck
Teaneck, US (HQ)
500 Glenpointe Centre W

Phibro Animal Health Corporation Data and Metrics

Phibro Animal Health Corporation Financial Metrics

Phibro Animal Health Corporation's revenue was reported to be $189.9 m in Q3, 2017

Revenue (Q3, 2017)

189.9 m

Gross profit (Q3, 2017)

60.6 m

Gross profit margin (Q3, 2017), %


Net income (Q3, 2017)

49.2 m

EBIT (Q3, 2017)

30 m

Market capitalization (21-Sep-2017)

1.4 b

Cash (31-Mar-2017)

49.3 m
Phibro Animal Health Corporation's current market capitalization is $1.4 b.
USDFY, 2014FY, 2015FY, 2016


691.9 m748.6 m751.5 m

Revenue growth, %


Cost of goods sold

484.1 m512.2 m512.5 m

Gross profit

207.8 m236.4 m239 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


187.5 m188.7 m187.5 m187.1 m191.8 m183.5 m188 m191.6 m189.9 m

Cost of goods sold

127.1 m132.6 m128.4 m127 m129.4 m123.5 m127 m128.1 m129.2 m

Gross profit

60.3 m56.1 m59.1 m60.2 m62.4 m60 m61 m63.5 m60.6 m

Gross profit Margin, %

USDFY, 2014FY, 2015FY, 2016


11.8 m29.2 m33.6 m

Accounts Receivable

113.9 m111.1 m123.8 m


30.4 m23.6 m5.2 m

Current Assets

299.3 m313.7 m342.8 m
USDQ1, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


19.7 m31.8 m25.4 m32.2 m37.4 m39.2 m49.3 m

Accounts Receivable

110.8 m113.7 m114.6 m116.2 m119.6 m124.1 m113.1 m


146.4 m147.3 m154.4 m168.3 m162.6 m158.8 m163.8 m

Current Assets

303.9 m317 m310.2 m332.6 m339.8 m339 m347.5 m
USDFY, 2014FY, 2015FY, 2016

Net Income

(3.1 m)60.3 m82.7 m

Depreciation and Amortization

21.5 m21.6 m23.5 m

Accounts Receivable

(14.7 m)(1.9 m)(13.1 m)


(31 k)7.4 m(6.9 m)
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

20.5 m35.9 m55.3 m18.8 m48.9 m67.5 m12.2 m25.6 m49.2 m

Depreciation and Amortization

5.4 m10.6 m16 m5.4 m10.8 m16.7 m6.3 m12.8 m19.6 m

Accounts Receivable

1.4 m(3.4 m)(6.9 m)(5.6 m)(6.9 m)(6.6 m)3.9 m(1.6 m)10 m

Accounts Payable

5.4 m(2 m)(1.2 m)(3 m)(4.8 m)(11.7 m)(5 m)(4.7 m)(6.4 m)
USDY, 2017


146 k

Financial Leverage

4.3 x
Show all financial metrics

Phibro Animal Health Corporation Operating Metrics

Phibro Animal Health Corporation's Customers was reported to be 3 k in FY, 2016, which is a 3% increase from the previous period
FY, 2015FY, 2016


2.9 k3 k
Show all operating metrics

Phibro Animal Health Corporation Market Value History

Traffic Overview of Phibro Animal Health Corporation

Phibro Animal Health Corporation Company Life and Culture

You may also be interested in